Fig. 4From: Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypesPatient survival correlates with epithelial-to-mesenchymal transition and invasiveness markers. Patients with a) high Anastassiou invasiveness signature activity, b) high SPARC gene expression and c) low KRAS G12 V pathway activity experience a worse outcomeBack to article page